$17.82
0.251.42%
Last update: Nov 6, 7:48 PM
Sarepta Therapeutics Inc
SRPTNASDAQ
Sarepta Therapeutics (SRPT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $0.13 | $0.32 | -59.4 % |
| Q2 | Aug 5, 2026 | $0.64 | $0.46 | 39.1 % |
| Q1 | May 6, 2026 | $3.16 | $0.91 | 247.3 % |
| Q4 | Feb 25, 2026 | $-3.58 | $-0.87 | -311.5 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.32 | $0.46 | $0.91 | $-0.87 |
| Actual | $0.13 | $0.64 | $3.16 | $-3.58 |
| Surprise | -59.4% | +39.1% | +247.3% | -311.5% |
| Revenue | ||||
| Estimate | $349.8M | $364.4M | $473.6M | $398.0M |
| Actual | $381.4M | $401.3M | $730.8M | $442.9M |
| Surprise | +9.04% | +10.1% | +54.3% | +11.3% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.03 | $0.63 | $0.26 | $0.29 |
| Revenue | ||||
| Consensus | $349.6M | $355.6M | — | — |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 5, 2026 | $381.40M | $349.78M | 9.04 % |
| Q2 | Aug 5, 2026 | $401.30M | $364.44M | 10.1 % |
| Q1 | May 6, 2026 | $730.80M | $473.58M | 54.3 % |
| Q4 | Feb 25, 2026 | $442.93M | $397.98M | 11.3 % |
